Literature DB >> 15020477

Enhancers and suppressors of testicular cancer susceptibility in single- and double-mutant mice.

Man-Yee Josephine Lam1, Kirsten K Youngren, Joseph H Nadeau.   

Abstract

Susceptibility to spontaneous testicular germ cell tumors (TGCTs), a common cancer affecting young men, shows unusual genetic complexity. Despite remarkable progress in the genetics analysis of susceptibility to many cancers, TGCT susceptibility genes have not yet been identified. Various mutations that are inherited as Mendelian traits in laboratory mice affect susceptibility to spontaneous TGCTs on the 129/Sv inbred genetic background. We compared the frequency of spontaneous TGCTs in single- and double-mutant mice to identify combinations that show evidence of enhancer or suppressor effects. The lower-than-expected TGCT frequencies in mice with partial deficiencies of TRP53 and MGF-SLJ and in 129.MOLF-Chr19 (M19) consomic mice that were heterozygous for the A(y) mutation suggest that either these genes complement each other to restore normal functionality in TGCT stem cells or together these genes activate mechanisms that suppress incipient TGCTs. By contrast, the higher-than-expected TGCT frequencies in Mgf(Sl-J)-M19 compound heterozygous mice suggest that these mutations exacerbate each other's effects. Together, these results provide clues to the genetic and molecular basis for susceptibility to TGCTs in mice and perhaps in humans.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15020477      PMCID: PMC1470739          DOI: 10.1534/genetics.166.2.925

Source DB:  PubMed          Journal:  Genetics        ISSN: 0016-6731            Impact factor:   4.562


  35 in total

Review 1.  Epidemiology of testicular cancer.

Authors:  S A Buetow
Journal:  Epidemiol Rev       Date:  1995       Impact factor: 6.222

2.  Susceptibility to testicular germ-cell tumours in a 129.MOLF-Chr 19 chromosome substitution strain.

Authors:  A Matin; G B Collin; Y Asada; D Varnum; J H Nadeau
Journal:  Nat Genet       Date:  1999-10       Impact factor: 38.330

3.  Alternative processing of the human and mouse raly genes(1).

Authors:  I Khrebtukova; A Kuklin; R P Woychik; E J Michaud
Journal:  Biochim Biophys Acta       Date:  1999-10-06

Review 4.  129/Sv mice--a model system for studying germ cell biology and testicular cancer.

Authors:  L I Jiang; J H Nadeau
Journal:  Mamm Genome       Date:  2001-02       Impact factor: 2.957

5.  Deficiency of Trp53 rescues the male fertility defects of Kit(W-v) mice but has no effect on the survival of melanocytes and mast cells.

Authors:  S A Jordan; R M Speed; F Bernex; I J Jackson
Journal:  Dev Biol       Date:  1999-11-01       Impact factor: 3.582

Review 6.  Disrupting TP53 in mouse models of human cancers.

Authors:  John M Parant; Guillermina Lozano
Journal:  Hum Mutat       Date:  2003-03       Impact factor: 4.878

Review 7.  Obesity, diabetes, and neoplasia in yellow A(vy)/- mice: ectopic expression of the agouti gene.

Authors:  T T Yen; A M Gill; L G Frigeri; G S Barsh; G L Wolff
Journal:  FASEB J       Date:  1994-05       Impact factor: 5.191

8.  Candidate regions for a testicular cancer susceptibility gene.

Authors:  M G Leahy; S Tonks; J H Moses; A R Brett; R Huddart; D Forman; R T Oliver; D T Bishop; J G Bodmer
Journal:  Hum Mol Genet       Date:  1995-09       Impact factor: 6.150

9.  The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus.

Authors:  B Chabot; D A Stephenson; V M Chapman; P Besmer; A Bernstein
Journal:  Nature       Date:  1988-09-01       Impact factor: 49.962

Review 10.  DNA damage, oncogenesis and the p53 tumour-suppressor gene.

Authors:  J M Lee; J L Abrahamson; A Bernstein
Journal:  Mutat Res       Date:  1994-06-01       Impact factor: 2.433

View more
  10 in total

Review 1.  Transgenerational genetic effects on phenotypic variation and disease risk.

Authors:  Joseph H Nadeau
Journal:  Hum Mol Genet       Date:  2009-10-15       Impact factor: 6.150

2.  Misexpression of cyclin D1 in embryonic germ cells promotes testicular teratoma initiation.

Authors:  Denise G Lanza; Emily P Dawson; Priya Rao; Jason D Heaney
Journal:  Cell Cycle       Date:  2016-02-22       Impact factor: 4.534

3.  Spontaneous metastasis in mouse models of testicular germ-cell tumours.

Authors:  J L Zechel; G T MacLennan; J D Heaney; J H Nadeau
Journal:  Int J Androl       Date:  2011-06-09

4.  Germ cell pluripotency, premature differentiation and susceptibility to testicular teratomas in mice.

Authors:  Jason D Heaney; Ericka L Anderson; Megan V Michelson; Jennifer L Zechel; Patricia A Conrad; David C Page; Joseph H Nadeau
Journal:  Development       Date:  2012-03-21       Impact factor: 6.868

Review 5.  Transgenerational genetic effects.

Authors:  Vicki R Nelson; Joseph H Nadeau
Journal:  Epigenomics       Date:  2010-12       Impact factor: 4.778

6.  Genetic factors on mouse chromosome 18 affecting susceptibility to testicular germ cell tumors and permissiveness to embryonic stem cell derivation.

Authors:  Philip D Anderson; Vicki R Nelson; Paul J Tesar; Joseph H Nadeau
Journal:  Cancer Res       Date:  2009-11-24       Impact factor: 12.701

7.  Loss of the transmembrane but not the soluble kit ligand isoform increases testicular germ cell tumor susceptibility in mice.

Authors:  Jason D Heaney; Man-Yee J Lam; Megan V Michelson; Joseph H Nadeau
Journal:  Cancer Res       Date:  2008-07-01       Impact factor: 12.701

8.  Deletion of eIF2beta suppresses testicular cancer incidence and causes recessive lethality in agouti-yellow mice.

Authors:  Jason D Heaney; Megan V Michelson; Kirsten K Youngren; Man-Yee J Lam; Joseph H Nadeau
Journal:  Hum Mol Genet       Date:  2009-01-23       Impact factor: 6.150

9.  Contrasting effects of Deadend1 (Dnd1) gain and loss of function mutations on allelic inheritance, testicular cancer, and intestinal polyposis.

Authors:  Jennifer L Zechel; Stephanie K Doerner; Angela Lager; Paul J Tesar; Jason D Heaney; Joseph H Nadeau
Journal:  BMC Genet       Date:  2013-06-17       Impact factor: 2.797

10.  Delayed male germ cell sex-specification permits transition into embryonal carcinoma cells with features of primed pluripotency.

Authors:  Emily P Dawson; Denise G Lanza; Nicholas J Webster; Susan M Benton; Isao Suetake; Jason D Heaney
Journal:  Development       Date:  2018-03-15       Impact factor: 6.862

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.